Outcome after cardiac arrest:: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale

被引:119
|
作者
Pfeifer, R
Börner, A
Krack, A
Sigusch, HH
Surber, R
Figulla, HR
机构
[1] Univ Jena, Dept Internal Med 1, Div Cardiol & Intens Care Med, D-07740 Jena, Germany
[2] Univ Jena, Inst Clin Chem, D-07740 Jena, Germany
[3] Univ Jena, Diagnost Lab, D-07740 Jena, Germany
关键词
cardiopulmonary resuscitation; outcome neuron-specific enolase; S-100; protein; Glasgow Coma Scale;
D O I
10.1016/j.resuscitation.2004.10.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background and purpose: Patients resuscitated from cardiac arrest are at risk of subsequent death or poor neurological outcome up to a persistent vegetative state. We investigated the prognostic value of several epidemiological and clinical markers and two neuroproteins, neuron-specific enolase (NSE) and S-100 protein (S-100), in 97 patients undergoing cardiopulmonary resuscitation (CPR) after non-traumatic cardiac arrest between 1998 and 2002. Results: 52.6% of the patients died, 28.8% survived with severe, moderate or without neurological disorders, and 18.6% remained in a persistent vegetative state. Unconsciousness > 48 h after CPR predicted a 60.6-fold (95% Cl 14.3287-257.205, p = 0.001) and a Glasgow Coma Scale (GCS) < 6 points after 72 h a 11.2-fold (CI 95%, 3.55-36.44, p < 0.001) risk of poor neurological outcome. Serum levels > 65 ng/ml for NSE and > 1.5 mu g/l for S-100 increased the risk of death and persistent vegetative state 16.8 (95% Cl 2.146-131.520)- and 12.6 (95% Cl 1.1093-99.210)- fold, respectively. By combination of the GCS with elevated serum concentrations of both neuroproteins above the cut off levels on third day after CPR a poor neurological outcome was predicted with a specificity of 100%. Conclusion: The combination of GCS with the serum levels of both neuroproteins at 72 It after CPR permit a more reliable prediction of outcome in post arrest coma than the single markers alone, independent of the application of anaesthetic agents. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [21] S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: Preliminary observation of a 6-month follow-up study
    Basile, AM
    Fusi, C
    Conti, AA
    Paniccia, R
    Trefoloni, G
    Pracucci, G
    Di Carlo, A
    Noferi, D
    Carbonetto, F
    Pretelli, P
    Calamai, G
    Vaccari, M
    Abbate, R
    Inzitari, D
    EUROPEAN NEUROLOGY, 2001, 45 (03) : 151 - 159
  • [22] Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study
    Daubin, Cedric
    Quentin, Charlotte
    Allouche, Stephane
    Etard, Olivier
    Gaillard, Cathy
    Seguin, Amelie
    Valette, Xavier
    Parienti, Jean-Jacques
    Prevost, Fabrice
    Ramakers, Michel
    Terzi, Nicolas
    Charbonneau, Pierre
    du Cheyron, Damien
    BMC CARDIOVASCULAR DISORDERS, 2011, 11
  • [23] 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Beaudry, P
    Cohen, P
    Brandel, JP
    Delasnerie-Lauprêtre, N
    Richard, S
    Launay, JM
    Laplanche, JL
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) : 40 - 46
  • [24] Time course of serum neuron-specific enolase - A predictor of neurological outcome in patients resuscitated from cardiac arrest
    Schoerkhuber, W
    Kittler, H
    Sterz, F
    Behringer, W
    Holzer, M
    Frossard, M
    Spitzauer, S
    Laggner, AN
    STROKE, 1999, 30 (08) : 1598 - 1603
  • [25] Predictive Performance of Neuron-Specific Enolase (NSE) for Survival after Resuscitation from Cardiac Arrest: A Systematic Review and Meta-Analysis
    Kurek, Krzysztof
    Swieczkowski, Damian
    Pruc, Michal
    Tomaszewska, Monika
    Cubala, Wieslaw Jerzy
    Szarpak, Lukasz
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [26] Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury
    Chabok, Shahrokh Yousefzadeh
    Moghadam, Anoush Dehnadi
    Saneei, Zahra
    Amlashi, Fatemeh Ghazanfari
    Leili, Ehsan Kazemnezhad
    Amiri, Zahra Mohtasham
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (06) : 1654 - 1657
  • [27] Usefulness of early plasma S-100B protein and Neuron-Specific Enolase measurements to identify cerebrovascular etiology of out-of-hospital cardiac arrest
    Mongardon, Nicolas
    Arnaout, Michel
    Geri, Guillaume
    Chenevier-Gobeaux, Camille
    Deye, Nicolas
    Legriel, Stephane
    Daviaud, Fabrice
    Merceron, Sybille
    Marin, Nathalie
    Pene, Frederic
    Mira, Jean-Paul
    Cariou, Alain
    RESUSCITATION, 2018, 130 : 61 - 66
  • [28] Combination of neuron-specific enolase measurement and initial neurological examination for the prediction of neurological outcomes after cardiac arrest
    Lee, Jae Hoon
    Kim, Yong Hwan
    Lee, Jun Ho
    Lee, Dong Woo
    Hwang, Seong Youn
    Youn, Chun Song
    Kim, Ji-Hoon
    Sim, Min Seob
    Jeung, Kyung Woon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] Diagnostic value of S-100 protein and neuron-specific enolase as serum markers for cerebral deficiency after general anaesthesia.: Study in patients with hip or knee replacement
    Linstedt, U
    Kropp, P
    Möller, C
    Zenz, M
    ANAESTHESIST, 2000, 49 (10): : 887 - 892
  • [30] Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures
    Palmio, J
    Peltola, J
    Vuorinen, P
    Laine, S
    Suhonen, J
    Keränen, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 183 (01) : 27 - 31